Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260572 · ClinicalTrials.gov registry record
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
A clinical trial of Gastroesophageal Reflux Disease, sponsored by University of Pittsburgh.
- Active
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT00260572: Active study of Gastroesophageal Reflux Disease, sponsored by University of Pittsburgh.
NCT00260572 is a study of Gastroesophageal Reflux Disease that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 2,500 participants, above the 256-participant average among 25 other Gastroesophageal Reflux Disease trials with a reported enrollment target (877% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260572, a study of Gastroesophageal Reflux Disease, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) issues and patient satisfaction; to refine the parameters that may identify patients who will benefit from surgery for GERD; and to identify possible determinants of failure of both medical and surgical treatments of reflux.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires to evaluate QOL
- BEHAVIORAL Questionnaires to evaluate heartburn and quality of life
- BEHAVIORAL Questionnaire to evaluate satisfaction with treatment
- BEHAVIORAL Questionnaire to evaluate presence or absence of pain
Study Locations (1)
Pennsylvania
- UPMC Department of Cardiothoracic Surgery - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1999-04 |
| Est. Completion | 2050-12 |
What the registry record for NCT00260572 still lists
NCT00260572 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 256-participant average among 25 other Gastroesophageal Reflux Disease trials with a reported enrollment target (877% higher).
The record links to 1 condition, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires to evaluate QOL is the first listed.
NCT00260572 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260572 about?
NCT00260572 is a clinical study titled "Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease". The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) iss...
What is the current status of trial NCT00260572?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 1999-04. Estimated completion is 2050-12.
What conditions does trial NCT00260572 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease.
What interventions are being tested in trial NCT00260572?
The interventions under investigation include: Questionnaires to evaluate QOL (BEHAVIORAL), Questionnaires to evaluate heartburn and quality of life (BEHAVIORAL), Questionnaire to evaluate satisfaction with treatment (BEHAVIORAL), Questionnaire to evaluate presence or absence of pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT00260572?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260572 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00260572's enrollment target sits among peer trials
2,500 2nd of 25 the highest of 25 other Gastroesophageal Reflux Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
RECRUITING
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
-
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia